Variant report

Variant	nsv600395
Chromosome Location	chr5:177675217-177707427
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:56)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:56 , 50 per page) page: 1 2

No.	Distal block	Cell Line	Cell type
1	chr5:177706927..177707599-chr5:177977871..177978610,3	MCF-7	breast:
2	chr5:177706743..177707559-chr5:178017553..178018241,3	MCF-7	breast:
3	chr5:177706757..177707961-chr5:178266041..178266913,4	MCF-7	breast:
4	chr5:177631652..177633817-chr5:177677988..177680794,2	K562	blood:
5	chr5:177664512..177669563-chr5:177672713..177676620,5	K562	blood:
6	chr5:177666154..177668382-chr5:177684774..177687012,2	MCF-7	breast:
7	chr5:177666998..177669633-chr5:177705585..177707860,2	MCF-7	breast:
8	chr5:177674781..177677713-chr5:177688724..177690382,2	MCF-7	breast:
9	chr5:177705017..177707369-chr5:177709194..177712378,3	K562	blood:
10	chr5:177637291..177640571-chr5:177674983..177676979,3	K562	blood:
11	chr5:177698904..177700407-chr5:177706155..177707702,2	K562	blood:
12	chr5:177688646..177691134-chr5:177692615..177694812,2	MCF-7	breast:
13	chr5:177682641..177685103-chr5:177687845..177689639,2	K562	blood:
14	chr5:177687306..177690029-chr5:177710452..177712944,2	MCF-7	breast:
15	chr5:177658492..177661017-chr5:177701580..177703752,2	MCF-7	breast:
16	chr5:177700241..177704563-chr5:177705321..177708218,5	MCF-7	breast:
17	chr5:177706996..177707580-chr5:177887844..177888573,2	K562	blood:
18	chr5:177706688..177707297-chr5:177977028..177977867,2	MCF-7	breast:
19	chr5:177673184..177676409-chr5:177679568..177684017,5	K562	blood:
20	chr5:177673184..177676409-chr5:177679568..177684017,5	K562	blood:
21	chr5:177682472..177686138-chr5:177686968..177690671,4	K562	blood:
22	chr5:177694652..177698387-chr5:177701947..177705005,3	MCF-7	breast:
23	chr5:177707050..177707576-chr5:177733039..177733583,2	MCF-7	breast:
24	chr5:177682641..177685103-chr5:177687845..177689639,2	K562	blood:
25	chr5:177688646..177691134-chr5:177692615..177694812,2	MCF-7	breast:
26	chr15:60690033..60690595-chr5:177692810..177693329,2	HCT-116	colon:
27	chr5:177706712..177707519-chr5:178016864..178017694,3	MCF-7	breast:
28	chr5:177706663..177708953-chr5:178261165..178263624,2	MCF-7	breast:
29	chr5:177667122..177671581-chr5:177672725..177675759,6	K562	blood:
30	chr5:177682472..177686138-chr5:177686968..177690671,4	K562	blood:
31	chr5:177671586..177674457-chr5:177675153..177677148,2	MCF-7	breast:
32	chr5:177694652..177698387-chr5:177701947..177705005,3	MCF-7	breast:
33	chr5:177706637..177707790-chr5:178017212..178018303,12	K562	blood:
34	chr5:177543150..177544003-chr5:177676886..177677587,2	MCF-7	breast:
35	chr5:177674663..177677489-chr5:177694652..177697569,3	K562	blood:
36	chr5:177706698..177707593-chr5:177977751..177978699,5	MCF-7	breast:
37	chr5:177674781..177677713-chr5:177688724..177690382,2	MCF-7	breast:
38	chr5:177679941..177681664-chr5:178053497..178055098,2	K562	blood:
39	chr5:177698904..177700407-chr5:177706155..177707702,2	K562	blood:
40	chr5:177676650..177677786-chr5:177737259..177738171,4	MCF-7	breast:
41	chr5:177631158..177632989-chr5:177704368..177706626,2	MCF-7	breast:
42	chr5:177623727..177624647-chr5:177706685..177707211,2	K562	blood:
43	chr5:177695402..177698313-chr5:177774135..177775779,2	K562	blood:
44	chr5:177705531..177707369-chr5:177709194..177711179,2	K562	blood:
45	chr5:177706726..177707270-chr5:178157310..178157911,2	MCF-7	breast:
46	chr5:177663359..177666352-chr5:177692543..177695366,2	K562	blood:
47	chr5:177665861..177669287-chr5:177672890..177677511,4	MCF-7	breast:
48	chr5:177680211..177682699-chr5:177684964..177686597,2	K562	blood:
49	chr5:177657753..177659482-chr5:177688552..177690642,2	MCF-7	breast:
50	chr5:177674663..177677489-chr5:177694652..177697569,3	K562	blood:

No data

Variant related genes	Relation type
ENSG00000197451	chromatin interactions
ENSG00000182718	chromatin interactions
ENSG00000175309	chromatin interactions
ENSG00000113240	chromatin interactions
ENSG00000169131	chromatin interactions
ENSG00000050767	chromatin interactions

Extended variants
information (count: 1532 )
Associated
traits (count: 102 )

Variant overlapped rSNPs/rCNVs (count:1532 , 50 per page) page: 1 2 3 4 5 6 7 ... 31

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs2913851	chr5:177675217-177675218	Weak transcription Genic enhancers Enhancers Strong transcription ZNF genes & repeats Bivalent Enhancer	n/a	n/a	Overlapped CNVs	mRNA abundance
2	rs188226394	chr5:177675222-177675223	Weak transcription Genic enhancers Enhancers Strong transcription ZNF genes & repeats Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs200471849	chr5:177675223-177675224	Weak transcription Genic enhancers Enhancers Strong transcription ZNF genes & repeats Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs111363480	chr5:177675264-177675265	Weak transcription Genic enhancers Enhancers Strong transcription ZNF genes & repeats Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs374679924	chr5:177675273-177675274	Weak transcription Genic enhancers Enhancers Strong transcription ZNF genes & repeats Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs368049371	chr5:177675289-177675290	Weak transcription Genic enhancers Enhancers Strong transcription ZNF genes & repeats Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs200248352	chr5:177675407-177675408	Weak transcription Genic enhancers Enhancers Strong transcription ZNF genes & repeats Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs181784413	chr5:177675417-177675418	Weak transcription Genic enhancers Enhancers Strong transcription ZNF genes & repeats Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs550968940	chr5:177675427-177675428	Weak transcription Genic enhancers Enhancers Strong transcription ZNF genes & repeats Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs569421673	chr5:177675459-177675460	Weak transcription Genic enhancers Enhancers Strong transcription ZNF genes & repeats Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs530400337	chr5:177675463-177675464	Weak transcription Genic enhancers Enhancers Strong transcription ZNF genes & repeats Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs6894255	chr5:177675465-177675466	Weak transcription Genic enhancers Enhancers Strong transcription ZNF genes & repeats Bivalent Enhancer	n/a	n/a	Overlapped CNVs	mRNA abundance
13	rs566719008	chr5:177675467-177675468	Weak transcription Genic enhancers Enhancers Strong transcription ZNF genes & repeats Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs2973755	chr5:177675493-177675494	Weak transcription Genic enhancers Enhancers Strong transcription ZNF genes & repeats Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs551814995	chr5:177675495-177675496	Weak transcription Genic enhancers Enhancers Strong transcription ZNF genes & repeats Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs570541808	chr5:177675654-177675655	Weak transcription Genic enhancers Enhancers Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs2973754	chr5:177675656-177675657	Weak transcription Genic enhancers Enhancers Strong transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs556099859	chr5:177675657-177675658	Weak transcription Genic enhancers Enhancers Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs574381906	chr5:177675703-177675704	Weak transcription Genic enhancers Enhancers Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs372235670	chr5:177675716-177675717	Weak transcription Genic enhancers Enhancers Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs375613233	chr5:177675747-177675748	Weak transcription Genic enhancers Enhancers Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs75474708	chr5:177675748-177675749	Weak transcription Genic enhancers Enhancers Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs557166306	chr5:177675807-177675808	Weak transcription Genic enhancers Enhancers Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs73338853	chr5:177675861-177675862	Weak transcription Genic enhancers Enhancers Strong transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs572226747	chr5:177675869-177675870	Weak transcription Genic enhancers Enhancers Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs546033918	chr5:177675911-177675912	Weak transcription Genic enhancers Enhancers Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs113489495	chr5:177675967-177675968	Weak transcription Genic enhancers Enhancers Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs369986281	chr5:177675987-177675988	Weak transcription Genic enhancers Enhancers Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs577290710	chr5:177676008-177676009	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs542467525	chr5:177676014-177676015	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs372399544	chr5:177676028-177676029	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs375792028	chr5:177676054-177676055	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs374754468	chr5:177676068-177676069	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs376130070	chr5:177676097-177676098	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs369728368	chr5:177676110-177676111	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs373602275	chr5:177676119-177676120	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs377286271	chr5:177676124-177676125	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs369829938	chr5:177676126-177676127	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs373322265	chr5:177676127-177676128	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs199565368	chr5:177676141-177676142	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs35229179	chr5:177676153-177676154	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs201398463	chr5:177676157-177676158	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs377334214	chr5:177676179-177676180	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs527845377	chr5:177676184-177676185	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs369459030	chr5:177676186-177676187	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs372995342	chr5:177676193-177676194	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs377159494	chr5:177676194-177676195	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs200804030	chr5:177676195-177676196	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs552374326	chr5:177676227-177676228	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs570982679	chr5:177676267-177676268	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:102)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	16751803	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Glioma	20126413	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
Thyroid cancer	19087340	CNVD
Acute myeloid leukemia	20729466	CNVD
lymphocytic leukemia	21291569	CNVD
Multiple myeloma	17550852	CNVD
Salivary gland tumor	18059337	CNVD
Renal cell carcinoma	19377443	CNVD
Lung cancer	18438408	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Renal cell carcinoma	18592004	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Prostate cancer	18632612	CNVD
epilepsy	18472482	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Sotos syndrome	21572526	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Sotos syndrome	17561922	CNVD
Sotos syndrome	16773131	CNVD
Mental retardation	16773131	CNVD
Sotos syndrome	22470819	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Acute myeloid leukemia	18000384	CNVD
Sudden cardiac death	19188705	CNVD
Basal cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Olfactory neuroblastoma	18408657	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
abnormal development	18461090	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Lung cancer	17297452	CNVD
Cancer	20164920	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21509527	CNVD
Breast cancer	21804112	CNVD
Myelofibrosis	22110671	CNVD
Sotos syndrome	22283845	CNVD
Breast cancer	16272173	CNVD
Sotos syndrome	20503325	CNVD
Lung adenocarcinoma	17086460	CNVD
Congenital Hypertrichosis Syndrome	21636067	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Breast cancer	19181860	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Ehlers-danlos syndrome	17576883	CNVD
Lung cancer	17086460	CNVD
Autism	19246517	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:305 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:177666400-177675800	Weak transcription	Esophagus	oesophagus
2	chr5:177669000-177676000	Weak transcription	GM12878-XiMat	blood
3	chr5:177669200-177677000	Weak transcription	Right Atrium	heart
4	chr5:177669600-177676200	Weak transcription	Liver	Liver
5	chr5:177669800-177699200	Weak transcription	Breast Myoepithelial Primary Cells	Breast
6	chr5:177670000-177675600	Weak transcription	Spleen	Spleen
7	chr5:177670000-177679200	Weak transcription	Primary hematopoietic stem cells	blood
8	chr5:177671800-177675600	Weak transcription	Monocytes-CD14+_RO01746	blood
9	chr5:177672800-177676000	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
10	chr5:177673000-177676000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
11	chr5:177673400-177676000	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
12	chr5:177673400-177676200	Enhancers	Primary T cells fromperipheralblood	blood
13	chr5:177673400-177677800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
14	chr5:177673400-177678000	Enhancers	Primary hematopoietic stem cells short term culture	blood
15	chr5:177673400-177678000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
16	chr5:177673800-177677400	Enhancers	Fetal Thymus	thymus
17	chr5:177674000-177681200	Weak transcription	Fetal Stomach	stomach
18	chr5:177674000-177682400	Weak transcription	HUES6 Cell Line	embryonic stem cell
19	chr5:177674200-177675600	ZNF genes & repeats	Foreskin Melanocyte Primary Cells skin01	Skin
20	chr5:177674200-177677600	Enhancers	Primary B cells from peripheral blood	blood
21	chr5:177674400-177677600	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
22	chr5:177674400-177689400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
23	chr5:177674600-177676000	Enhancers	Primary T helper naive cells from peripheral blood	blood
24	chr5:177674600-177677400	Enhancers	Primary T helper naive cells fromperipheralblood	blood
25	chr5:177674600-177677800	Enhancers	Primary T killer naive cells fromperipheralblood	blood
26	chr5:177674800-177675600	Weak transcription	Primary T helper cells fromperipheralblood	blood
27	chr5:177674800-177676000	Enhancers	Primary B cells from cord blood	blood
28	chr5:177674800-177677200	Enhancers	Primary T helper cells PMA-I stimulated	--
29	chr5:177674800-177677600	Strong transcription	Cortex derived primary cultured neurospheres	brain
30	chr5:177675000-177675400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
31	chr5:177675000-177675400	Enhancers	Fetal Muscle Leg	muscle
32	chr5:177675200-177676000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
33	chr5:177675200-177677000	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
34	chr5:177675400-177677200	Weak transcription	Fetal Muscle Leg	muscle
35	chr5:177675400-177677600	Enhancers	Primary T killer memory cells from peripheral blood	blood
36	chr5:177675600-177676400	Enhancers	Spleen	Spleen
37	chr5:177675600-177677200	Enhancers	Monocytes-CD14+_RO01746	blood
38	chr5:177675600-177677600	Enhancers	Primary T helper cells fromperipheralblood	blood
39	chr5:177675800-177677400	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
40	chr5:177675800-177677400	Enhancers	Esophagus	oesophagus
41	chr5:177675800-177677600	Enhancers	Right Ventricle	heart
42	chr5:177676000-177676400	Bivalent Enhancer	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
43	chr5:177676000-177676400	Flanking Active TSS	Primary T helper naive cells from peripheral blood	blood
44	chr5:177676000-177676600	Flanking Active TSS	Primary Natural Killer cells fromperipheralblood	blood
45	chr5:177676000-177676600	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
46	chr5:177676000-177676600	Enhancers	HMEC	breast
47	chr5:177676000-177676800	Weak transcription	Primary B cells from cord blood	blood
48	chr5:177676000-177677000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
49	chr5:177676000-177677400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
50	chr5:177676000-177677800	Enhancers	GM12878-XiMat	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links